Multifunctional Doxorubicin@Hollow-Cu9S8 nanoplatforms for Photothermally-Augmented Chemodynamic-Chemo therapy

Xiaohan Liu,Peng Geng,Nuo Yu,Zheng Xie,Yirou Feng,Qin Jiang,Maoquan Li,Ye Song,Weishuai Lian,Zhigang Chen
DOI: https://doi.org/10.1016/j.jcis.2022.01.156
IF: 9.9
2022-06-01
Journal of Colloid and Interface Science
Abstract:Multimodal therapy has attracted increasing interests in tumor treatment due to its high anti-cancer efficacy, and the key is to develop multifunctional nanoagents. The classic multifunctional nanoagents are made up of expensive and complex components, leading to limited practical applications. To solve these problems, we have developed the polyethylene glycol (PEG) coated hollow Cu9S8 nanoparticles (H-Cu9S8/PEG NPs), whose H-Cu9S8 component exhibits the photothermal effect for near-infrared (NIR) photothermal therapy (PTT), the Fenton-like catalytic activity for chemodynamic therapy (CDT), and the drug-loading capacity for chemotherapy. The H-Cu9S8/PEG NPs with a diameter of ∼ 100 nm have been synthesized by sulfurizing cuprous oxide (Cu2O) nanoparticles through "Kirkendall effect", and they exhibit high photothermal conversion efficiency of 40.9%. Meanwhile, the H-Cu9S8/PEG NPs are capable of a Fenton-like reaction, which can be augmented by 2 times under the NIR irradiation. The hollow structure gives the H-Cu9S8/PEG high doxorubicin (DOX) loading capacity (21.1%), and then the DOX release can be further improved by pH and photothermal effect. When the 9S8/PEG dispersions are injected into the tumor-bearing mice, the tumor growth can be efficiently inhibited due to the synergistic effect of photothermally-augmented CDT-chemo therapy. Therefore, the 9S8/PEG can serve as a multifunctional nanoplatform for photothermally-augmented CDT-chemo treatment of malignant tumors.
chemistry, physical
What problem does this paper attempt to address?
The paper aims to address several key issues in the treatment of malignant tumors. Specifically, it proposes a multifunctional nanoplatform—hollow Cu9S8 nanoparticles (H-Cu9S8/PEG)—to achieve photothermally-augmented chemodynamic-chemo therapy. The main issues addressed include: 1. **Enhancing Chemotherapy Efficacy**: By loading chemotherapeutic drugs (such as Doxorubicin DOX) into the nanoparticles and utilizing photothermal and chemodynamic effects to enhance the efficacy of chemotherapy. 2. **Controlled Drug Release**: By designing nanoparticles with a hollow structure, enabling controlled drug release under acidic and photothermal conditions, thereby improving targeting and reducing side effects. 3. **Overcoming the Limitations of Single Therapy**: By combining photothermal therapy (PTT), chemodynamic therapy (CDT), and chemotherapy, achieving a synergistic effect to improve overall therapeutic outcomes. The paper experimentally validated the antitumor effects of this nanoplatform in mice, demonstrating its potential in the treatment of malignant tumors.